| a focus of rocky mountain spotted fever within new york city. | in the spring and summer of 1987, four persons acquired rocky mountain spotted fever within new york city, an area in which the disease had not previously been known to be endemic. three of the four patients were residents of the soundview area of the bronx. all diagnoses were confirmed by indirect fluorescent-antibody tests. environmental investigation revealed that the tick vector for rickettsia rickettsii, dermacentor variabilis, was present in a local park. of the 66 specimens of d. variabil ... | 1988 | 3130574 |
| rickettsialpox: report of an outbreak and a contemporary review. | rickettsialpox is a mild illness characterized by the appearance of a primary eschar at the site of a mite bite followed by fever, headache, and a papulovesicular rash. it can be confused with a variety of illnesses including several other rickettsial diseases and chickenpox. r. akari, the etiologic agent, is a rickettsia belonging to the spotted fever group (sfg) of rickettsial illnesses. in spite of significant serologic cross-reactivity with other sfg agents, there is no convincing evidence o ... | 1981 | 7278620 |
| seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast united states. | to determine the prevalence of serologic reactivity, the 1-year incidence of seroconversion, and the frequency of multiple infections, and their associations with symptoms in a group of volunteers at high risk for tick-borne infections in new york state. | 1999 | 10225242 |
| serologic evidence of rickettsia akari infection among dogs in a metropolitan city. | to determine whether dogs in new york, ny are naturally infected with rickettsia akari, the causative agent of rickettsialpox in humans. | 2001 | 11394829 |
| evidence of rodent-associated bartonella and rickettsia infections among intravenous drug users from central and east harlem, new york city. | we tested serum samples collected in 1997 and 1998 from a cohort of 204 injection drug users (idus) recruited from central and east harlem, new york city, new york, for antibodies reactive with seven rickettsial or bartonella spp. antigens. rodent-associated bartonella elizabethae and rickettsia akari were the primary etiologic agents of interest. the testing panel also included bartonella henselae, bartonella quintana, rickettsia prowazekii, rickettsia rickettsii, and rickettsia typhi. the high ... | 2001 | 11791987 |
| rickettsialpox in new york city: a persistent urban zoonosis. | rickettsialpox, a spotted fever rickettsiosis, was first identified in new york city (nyc) in 1946. during the next five years, approximately 540 additional cases were identified in nyc. however, during the subsequent five decades, rickettsialpox received relatively little attention from clinicians and public health professionals, and reporting of the disease diminished markedly. during february 2001 through august 2002, 34 cases of rickettsialpox in nyc were confirmed at cdc from cutaneous biop ... | 2003 | 12860597 |
| increased detection of rickettsialpox in a new york city hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism. | rickettsialpox is a self-limited febrile illness with skin lesions that may be mistaken for signs of potentially more serious diseases, such as cutaneous anthrax or chickenpox. the cluster of cutaneous anthrax cases from bioterrorism in october 2001 likely heightened awareness of and concern for cutaneous eschars. | 2003 | 14676069 |